Lv21
120 积分 2025-03-04 加入
TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study
5小时前
已完结
Decoding the spatial dynamics of tumor and immune cell interactions in solid cancers
5小时前
已完结
Degrader-Drug Conjugate (DDC) Mediated Immunochemotherapy for Tumor Treatment
5小时前
已完结
Advances in Peptide-Based Chimeric Strategies for Targeted Protein Degradation
5小时前
已完结
Discovery of PKMYT1 Inhibitors with a Novel Scaffold for the Treatment of Triple-Negative Breast Cancer
6小时前
已完结
Discovery of Fused Isoquinolinone/Triazole as a Scaffold for Tankyrase and PARP Inhibition
6小时前
已完结
Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9
28天前
已完结
Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective
28天前
已完结
Discovery and Development of a Small-Molecule Inhibitor Targeting the GAS41 YEATS Domain in Nonsmall Cell Lung Cancer
28天前
已完结
Discovery of Potent, Selective and Efficacious Aminopyrazole Inhibitors of PLK4
28天前
已完结
皖公网安备34019202002308
